0
Research Letters |

Intraretinal Neovascularization in Diabetic Retinopathy FREE

Alan D. Proia, MD, PhD; Matthew C. Caldwell, MD
[+] Author Affiliations

Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Ophthalmol. 2010;128(1):142-144. doi:10.1001/archophthalmol.2009.338
Text Size: A A A
Published online
Figures in this Article

The hallmark of proliferative diabetic retinopathy is neovascularization occurring at the vitreoretinal interface and in the vitreous,1 although intraretinal neovascularization (IRNV) is also reported to be a common finding if repeated fluorescein angiography is performed.2 3 However, the appearance of the IRNV in routine histological sections has been reported only rarely.4 Herein, we describe the histological features of IRNV in both eyes of a man with chronic diabetes mellitus.

A 53-year-old man with chronic diabetes mellitus, hypertension, chronic kidney disease,coronary artery disease, and congestive heart failure fell out of bed. The next morning he was unresponsive; a computed tomographic scan disclosed a large right subdural hematoma with 3 cm of a right-to-left midline shift of the brain and uncal herniation. He had fixed and dilated pupils, a Glasgow Coma Scale score of 3, and no spontaneous respirations or evidence of brain stem function. The patient was declared brain-dead and died shortly after having the ventilator removed. There was no recorded ophthalmic history or eye examination.

Both eyes were enlarged, measuring 28 × 28 × 28 mm. On sectioning, both eyes had innumerable 0.1- to 1.0-mm-diameter retinal hemorrhages surrounding the macula. Microscopically, the neurosensory retina of both eyes had occasional thick-walled blood vessels and other vessels with occlusive fibrin microthrombi, some of which may have been an agonal event. Some arterioles with fibrin microthrombi had dual lumina typical of recanalization or intravascular endothelial proliferation. Other vessels exhibited vascular proliferation (Figure 1) with glomeruloid5 and angiomatoid6 appearances. Immunostains using antibodies to factor VIII–related antigen and CD34 confirmed the vascular identity (Figure 2). Widespread hemorrhages appeared throughout the neurosensory retina along with a few hemosiderin-laden macrophages around some retinal arterioles. Epiretinal membranes appeared in both eyes; the left retina had a few microinfarcts of the nerve fiber layer, cystoid macular edema, and serous exudates in the outer plexiform layer; and both eyes had low-lying serous detachments of the macular neurosensory retina as well as focal chorioretinal scars.

Place holder to copy figure label and caption
Figure 1.

Dilated and proliferated blood vessels at the level of the retinal ganglion cell layer. Fibrin thrombus (asterisk) is present in the vessel on the right (hematoxylin-eosin).

Grahic Jump Location
Place holder to copy figure label and caption
Figure 2.

Endothelial cells in a proliferation of vessels are highlighted using antibodies to CD34 (anti-CD34 immunostain).

Grahic Jump Location

Takahashi et al3 noted IRNV in 54 of 94 eyes (57%) when repeated fluorescein angiography was used to examine patients with diabetes mellitus having nonperfused areas of retina.2 The IRNV occurred as capillaries that budded from a venule and grew to form a network.3 The IRNV developed in eyes with nonproliferative diabetic retinopathy or developed concomitantly with or after the appearance of new blood vessels at the vitreoretinal interface.2

Despite the frequency with which IRNV is noted by fluorescein angiography, we found only 1 report of the microscopic features of this condition in human eyes in routine histological sections.4 Our histological findings were similar to those by Imesch et al,4 who examined the eyes from 5 individuals with diabetic retinopathy and noted intraretinal neovascular lesions consisting of “multiple microvascular lumina spaced closely together and enveloped by a thick perivascular cuff”4 containing collagen fibrils. The IRNV and preretinal neovascularization were sometimes contiguous.4

Vascular endothelial growth factor has been implicated in the pathogenesis of proliferative diabetic retinopathy,1 and the histological appearance of the IRNV in these eyes is similar to that induced by intradermal injection of vascular endothelial growth factor in mice.5 The IRNV also resembles plexiform and angiomatoid lesions in lungs with pulmonary hypertension.6 Factors implicated in the pathogenesis of pulmonary plexiform lesions include overexpression of vascular endothelial growth factor, endothelin 1, and survivin; reduced expression of vascular antiremodeling mediators such as nitric oxide synthase and prostacyclin synthase; loss of expression of transforming growth factor β receptor 2 and proapoptotic Bax; and mutations in bone morphogenetic protein receptor 2, a component of the transforming growth factor β family.6 The similarity of IRNV with pulmonary plexiform lesions suggests potential avenues for investigating the pathogenesis of proliferative diabetic retinopathy.

Correspondence: Dr Proia, Department of Pathology, Duke University Medical Center, DUMC 3712, Durham, NC 27710 (proia001@mc.duke.edu).

Financial Disclosure: None reported.

Kroll  P, Rodrigues  EB, Hoerle  S. Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 2007;221 (2) 78- 94
PubMed
Muraoka  K, Shimizu  K. Intraretinal neovascularization in diabetic retinopathy. Ophthalmology 1984;91 (12) 1440- 1446
PubMed
Takahashi  K, Kishi  S, Muraoka  K, Shimizu  K. Reperfusion of occluded capillary beds in diabetic retinopathy. Am J Ophthalmol 1998;126 (6) 791- 797
PubMed
Imesch  PD, Bindley  CD, Wallow  IH. Clinicopathologic correlation of intraretinal microvascular abnormalities. Retina 1997;17 (4) 321- 329
PubMed
Sundberg  C, Nagy  JA, Brown  LF.  et al.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 2001;158 (3) 1145- 1160
PubMed
Tuder  RM, Marecki  JC, Richter  A, Fijalkowska  I, Flores  S. Pathology of pulmonary hypertension. Clin Chest Med 2007;28 (1) 23- 42, vii
PubMed

First Page Preview

First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.

Dilated and proliferated blood vessels at the level of the retinal ganglion cell layer. Fibrin thrombus (asterisk) is present in the vessel on the right (hematoxylin-eosin).

Grahic Jump Location
Place holder to copy figure label and caption
Figure 2.

Endothelial cells in a proliferation of vessels are highlighted using antibodies to CD34 (anti-CD34 immunostain).

Grahic Jump Location

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Kroll  P, Rodrigues  EB, Hoerle  S. Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica 2007;221 (2) 78- 94
PubMed
Muraoka  K, Shimizu  K. Intraretinal neovascularization in diabetic retinopathy. Ophthalmology 1984;91 (12) 1440- 1446
PubMed
Takahashi  K, Kishi  S, Muraoka  K, Shimizu  K. Reperfusion of occluded capillary beds in diabetic retinopathy. Am J Ophthalmol 1998;126 (6) 791- 797
PubMed
Imesch  PD, Bindley  CD, Wallow  IH. Clinicopathologic correlation of intraretinal microvascular abnormalities. Retina 1997;17 (4) 321- 329
PubMed
Sundberg  C, Nagy  JA, Brown  LF.  et al.  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am J Pathol 2001;158 (3) 1145- 1160
PubMed
Tuder  RM, Marecki  JC, Richter  A, Fijalkowska  I, Flores  S. Pathology of pulmonary hypertension. Clin Chest Med 2007;28 (1) 23- 42, vii
PubMed

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles